Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2875 of 3173 entries
View as:

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03804125 Org: User:
Start: 09/01/21 End: 03/01/24 Due: 03/01/25

Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02378506 Org: User:
Start: 04/30/15 End: 06/30/16 Due: 06/30/17

A Study of Vepdegestrant (ARV-471, PF-07850327) Plus Palbociclib Versus Letrozole Plus Palbociclib in Participants With Estrogen Receptor Positive, Human Epidermal Growth Factor Negative Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05909397 Org: User:
Start: 08/09/23 End: 12/30/26 Due: 12/30/27

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT06057402 Org: User:
Start: 10/03/23 End: 02/22/32 Due: 02/22/33

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06641466 Org: User:
Start: 03/11/25 End: 03/30/27 Due: 03/30/28

Single Dose Study of PF-04991532 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01102673 Org: User:
Start: 04/30/10 End: 06/30/10 Due: 06/30/11

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00962741 Org: User:
Start: 09/30/09 End: 01/31/13 Due: 01/31/14

An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend

Phase: N/A Priority: Normal
NCT ID: NCT00150319 Org: User:
Start: 06/30/05 End: 10/31/05 Due: 10/31/06

Evaluation Of The Relative Bioavailability Of PF-04457845 Tablet To Solution Formulation And Food Effect In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00918164 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00373256 Org: User:
Start: 11/30/06 End: 08/31/11 Due: 08/31/12

Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom

Phase: N/A Priority: Normal
NCT ID: NCT01202253 Org: User:
Start: 02/28/11 End: 05/31/11 Due: 05/31/12

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01044537 Org: User:
Start: 02/28/10 End: 05/31/10 Due: 05/31/11

A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption

Phase: N/A Priority: Normal
NCT ID: NCT01366287 Org: User:
Start: 01/31/11 End: 02/28/11 Due: 02/28/12

Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00550329 Org: User:
Start: 10/31/07 End: 11/30/07 Due: 11/30/08

A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01140672 Org: User:
Start: 06/30/10 End: 10/31/10 Due: 10/31/11

Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00694044 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings

Phase: N/A Priority: Normal
NCT ID: NCT00884390 Org: User:
Start: 05/31/09 End: 03/31/13 Due: 03/31/14

Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients

Phase: N/A Priority: Normal
NCT ID: NCT00895050 Org: User:
Start: 03/31/09 End: 01/31/11 Due: 01/31/12

A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00068042 Org: User:
Start: 04/30/03 End: 05/31/06 Due: 05/31/07

Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01102660 Org: User:
Start: 05/31/10 End: 03/31/11 Due: 03/31/12

Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01181973 Org: User:
Start: 10/31/10 End: 01/31/11 Due: 01/31/12

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01780987 Org: User:
Start: 01/31/13 End: 09/30/14 Due: 09/30/15

A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01020136 Org: User:
Start: 01/31/10 End: 02/28/10 Due: 02/28/11

Litfulo Capsules Special Investigation

Phase: N/A Priority: Normal
NCT ID: NCT06279221 Org: User:
Start: 03/01/24 End: 06/25/30 Due: 06/25/31

Voxelotor Brain Oxygenation and Neurocognitive Study

Phase: N/A Priority: Normal
NCT ID: NCT05228821 Org: User:
Start: 08/09/23 End: 08/23/23 Due: 08/23/24